Liquid Biopsy in Cancer Diagnostics Global Market is Likely to Increase at a Massive Growth Rate of ~17% by 2030 | DelveInsight

DelveInsight's Liquid Biopsy in Cancer Diagnostics Market Insights report provides the current and forecast market analysis, individual leading liquid biopsy in cancer diagnostics companies' market shares, challenges, liquid biopsy in cancer diagnostics market drivers, barriers, trends, and key market liquid biopsy in cancer diagnostics companies in the market.

To read more about the latest highlights related to liquid biopsy in cancer diagnostics market, get a snapshot of the key highlights entailed in the Global Liquid Biopsy in Cancer Diagnostics Market Report- https://www.delveinsight.com/sample-request/liquid-biopsy-in-cancer-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Liquid Biopsy in Cancer Diagnostics Market
• As per DelveInsight estimates, North America is anticipated to dominate the global liquid biopsy in cancer diagnostics market during the forecast period.
• Global liquid biopsy in cancer diagnostics market was valued at USD 7.64 billion in 2023, growing at a CAGR of 16.64% during the forecast period from 2024 to 2030 to reach USD 19.24 billion by 2030.
• The leading Liquid Biopsy in Cancer Diagnostics Companies such as Myriad Genetics Inc, Exact Sciences Corporation, Biocartis, Sysmex Corporation, Thermo Fisher Scientific Inc, Biocept Inc, Agilent Technologies Inc., MDx Health, Neogenomics Laboratories, F. Hoffman La Roche Ltd, Guardant Health, Bio-Techne, Illumina Inc, QIAGEN, Lucence Health Inc, Personal Gemone Diagnostics Inc, SAGA Diagnostics, Agena Bioscience Inc, The Menarini Group, MiRXES Pte Ltd and others.

To know more about why North America is leading the market growth in the liquid biopsy in cancer diagnostics market, get a snapshot of the Liquid Biopsy in Cancer Diagnostics Market Outlook- https://www.delveinsight.com/sample-request/liquid-biopsy-in-cancer-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Liquid Biopsy in Cancer Diagnostics Market Dynamics
One of the key aspects driving the liquid biopsy in cancer diagnostics market is the growing demand for liquid biopsy in cancer diagnostics due to increase in the cancer incidence. For instance, as per the GLOBOCAN study conducted by the International Agency for Research on Cancer, in 2020, an estimated number of 19.3 million new cancer cases (18.1 million excluding non-melanoma skin cancer) and near about 10.0 million cancer deaths were reported globally. The above-mentioned source further stated that in 2020, lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Considering the increase in the number of new cancer cases all over the globe, there has been a growing emphasis on developing an alternative to conventional biopsies to facilitate the cancer diagnosis process and make it smoother for both patients and healthcare providers. Furthermore, the application of liquid biopsy in therapy management for cancers such as lung and breast is further expected to boost the product demand. Thus, the increasing patient population of cancers would, in turn, lead to an increase in demand for liquid biopsy products and services.

Liquid Biopsy in Cancer Diagnostics Market Segment Analysis
Liquid Biopsy in Cancer Diagnostics Market by Type (Product Type [Instruments and Reagents & Kits] and Services), Sample Type (Blood, Urine, and Saliva), Biomarker Type (Circulating Tumor Cells, Circulating Tumor DNA, Circulating Free DNA, and Others), Cancer Type (Lung Cancer, Breast Cancer, Colon Cancer, and Others), Technique (Polymerase Chain Reaction and Next Generation Sequencing), End-User (Hospitals, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Get a sneak peek at the liquid biopsy in cancer diagnostics market dynamics @ Liquid Biopsy in Cancer Diagnostics Market Dynamics Analysis- https://www.delveinsight.com/sample-request/liquid-biopsy-in-cancer-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Liquid Biopsy in Cancer Diagnostics Companies
Myriad Genetics Inc, Exact Sciences Corporation, Biocartis, Sysmex Corporation, Thermo Fisher Scientific Inc, Biocept Inc, Agilent Technologies Inc., MDx Health, Neogenomics Laboratories, F. Hoffman La Roche Ltd, Guardant Health, Bio-Techne, Illumina Inc, QIAGEN, Lucence Health Inc, Personal Gemone Diagnostics Inc, SAGA Diagnostics, Agena Bioscience Inc, The Menarini Group, MiRXES Pte Ltd and others.

Global Liquid Biopsy in Cancer Diagnostics Market Drivers
Factors such as the rising incidence of various cancers, growing demand for minimally invasive procedures, increasing prominence of precision medicine, technical innovation in product development among other factors are expected to drive the liquid biopsy in cancer diagnostics market.

Which MedTech key players in the liquid biopsy in cancer diagnostics market are set to emerge as the trendsetter explore @ Liquid Biopsy in Cancer Diagnostics Companies- https://www.delveinsight.com/sample-request/liquid-biopsy-in-cancer-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Liquid Biopsy in Cancer Diagnostics Market Report
• Coverage- Global
• Liquid Biopsy in Cancer Diagnostics Companies- Myriad Genetics Inc, Exact Sciences Corporation, Biocartis, Sysmex Corporation, Thermo Fisher Scientific Inc, Biocept Inc, Agilent Technologies Inc., MDx Health, Neogenomics Laboratories, F. Hoffman La Roche Ltd, Guardant Health, Bio-Techne, Illumina Inc, QIAGEN, Lucence Health Inc, Personal Gemone Diagnostics Inc, SAGA Diagnostics, Agena Bioscience Inc, The Menarini Group, MiRXES Pte Ltd and others.
• Liquid Biopsy in Cancer Diagnostics Market Segmentation By Technique: Polymerase Chain Reaction and Next Generation Sequencing
• Liquid Biopsy in Cancer Diagnostics Market Segmentation By End User: Hospitals, Diagnostic Centers, and Others
• Liquid Biopsy in Cancer Diagnostics Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Liquid Biopsy in Cancer Diagnostics Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing the liquid biopsy in cancer diagnostics market by 2030? Click to get a snapshot of the Liquid Biopsy in Cancer Diagnostics Market Trends- https://www.delveinsight.com/sample-request/liquid-biopsy-in-cancer-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Liquid Biopsy in Cancer Diagnostics Market Report Introduction
2. Liquid Biopsy in Cancer Diagnostics Market Executive Summary
3. Regulatory Analysis
4. Liquid Biopsy in Cancer Diagnostics Market Key Factor Analysis
5. Liquid Biopsy in Cancer Diagnostics Market Porter's Five Forces Analysis
6. Liquid Biopsy in Cancer Diagnostics Market Layout
7. Liquid Biopsy in Cancer Diagnostics Market Company and Product Profiles
8. KOL Views
9. Project Approach
10. DelveInsight Capabilities
11. About DelveInsight
12. Disclaimer & Contact Us

List of Top Selling Market Research Reports in 2025

Biopsy devices market- https://www.delveinsight.com/report-store/biopsy-devices-market
Diabetic wound market - https://www.delveinsight.com/report-store/diabetic-wounds-market
Joint reconstruction devices market- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Cystic fibrosis market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Heart failure market- https://www.delveinsight.com/report-store/congestive-heart-failure-market
NK Cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Positive airway pressure device market - https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
Stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Thyroid cancer market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Urinary catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Uterine fibroids market- https://www.delveinsight.com/report-store/uterine-leiomyoma-uterine-fibroids-market
Attention deficit hyperactivity disorder adhd market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lice infestations market- https://www.delveinsight.com/report-store/lice-infestations-market
Lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.